Targeting PIN1 as a Therapeutic Approach for Hepatocellular Carcinoma
PIN1 is a peptidyl-prolyl cis/trans isomerase that specifically binds and catalyzes the cis/trans isomerization of the phosphorylated serine or threonine residue preceding a proline (pSer/Thr-Pro) motif of its interacting proteins. Through this phosphorylation-dependent prolyl isomerization, PIN1 is...
Main Authors: | Chi-Wai Cheng, Eric Tse |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcell.2019.00369/full |
Similar Items
-
Targeted Therapies for Hepatocellular Carcinoma Treatment: A New Era Ahead—A Systematic Review
by: Christos Damaskos, et al.
Published: (2022-11-01) -
PIN1 in Cell Cycle Control and Cancer
by: Chi-Wai Cheng, et al.
Published: (2018-11-01) -
The Role of SNHG15 in the Pathogenesis of Hepatocellular Carcinoma
by: Christos Damaskos, et al.
Published: (2022-05-01) -
Hepatitis B Virus-Associated Hepatocellular Carcinoma and Chronic Stress
by: Nicholas Noverati, et al.
Published: (2022-04-01) -
Protective Role of Decorin in Primary Hepatocellular Carcinoma
by: Andrea Reszegi, et al.
Published: (2020-05-01)